1. Update on the pathology of liver neoplasms
   Karen E. Matsukuma et al, 2019, Annals of Diagnostic Pathology CrossRef
2. The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver
   Osama H. Labib et al, 2020, Journal of Gastrointestinal Cancer CrossRef
3. Role of arginase 1 immunohistochemical marker in differentiating hepatocellular carcinoma from other primary and secondary carcinomas of the liver, a tissue microarray study
   Shaimaa M Yussif et al, 2022, Indian Journal of Pathology and Oncology CrossRef
4. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1
   Nehal A Radwan et al, 2012, Diagnostic Pathology CrossRef
5. Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma
   Teresa Pollicino et al, 2019, Oncotarget CrossRef
6. Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas
   Hanlin L. Wang et al, 2017, Archives of Pathology & Laboratory Medicine CrossRef
7. HepPar-1 Expression in Primary Lung Adenocarcinoma
   Samuel A. Yousem et al, 2013, American Journal of Clinical Pathology CrossRef
8. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma
   Thuy Nguyen et al, 2015, Archives of Pathology & Laboratory Medicine CrossRef
9. Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma
   Maximilian Lennartz et al, 2021, Diagnostics CrossRef